- Bookmark
- Share
- CaseIQ
Bayer Cropscience KK v Charles River Laboratories Preclinical Services Edinburgh Ltd & Anor
Factual and Procedural Background
The Plaintiff is Company A, a corporation incorporated under the laws of Japan, engaged in the development and marketing of pesticides and insecticides. It was the proprietor of a European Patent (UK) relating to insecticidal agents containing new heterocyclic compounds, specifically a compound generically named "imidacloprid." The patent expired on 31 March 2006. A similar US patent expired on 21 January 2006.
The first Defendant is a commercial research organisation based in Scotland offering research and development services for pharmaceutical, animal health, chemical, and agrochemical manufacturers. The second Defendant, Company B, incorporated under the laws of Iowa, USA, is a competitor of the Plaintiff.
In March 2005, Company B sought registration with the Environmental Protection Agency (EPA) in the USA for an insecticide containing the patented compound as its active ingredient, a necessary step before marketing the product. The EPA required chemistry test data related to the active ingredient. Company B instructed the first Defendant to conduct tests and produce the required data, which was submitted to the EPA in March and May 2005.
The Plaintiff did not supply the product to either Defendant and has never sold the product alone, only as part of an end product. Company B imported the active ingredient from China to the UK for testing. Company B admits that these acts occurred before the patent expired and that the importation and testing infringed the Plaintiff's patent. Company B contends that the infringement was undertaken to secure EPA registration in time to place the insecticide on the US market shortly after the patent's expiry, asserting that sales commenced in April 2006 and that all profits were earned post-expiry.
The Plaintiff seeks an order for an account of profits made by Company B from the infringement. The claim comprises two parts: (1) profits made during 2006, argued to be attributable to the infringement as Company B could not have marketed the product until December 2006 absent the infringement; and (2) enhanced sales in 2007 and 2008 resulting from the early market entry, described as a "springboard" claim. The case against the first Defendant has been resolved outside court.
Legal Issues Presented
- Whether the court has the power to order an account of profits derived from acts of patent infringement that preceded lawful sales occurring after patent expiry.
- Whether profits earned post-patent expiry can be attributed to the infringement committed prior to expiry, particularly in the context of a "springboard" claim.
- The extent to which causation and legal principles of unfair profit apply to the calculation of profits attributable to infringement versus lawful commercial activities.
Arguments of the Parties
Second Defendant's Arguments
- The court lacks power to order an account of profits in these circumstances, as profits were derived from lawful post-expiry sales, not from the infringing acts themselves.
- The infringement was merely a precursor to profit-generating activities occurring after patent expiry; thus, profits cannot be said to be "derived from the infringement" under section 61(1)(d) of the Patents Act 1977.
- The claim is irrelevant and should be dismissed because the infringing acts were not commercial transactions capable of generating profit.
Plaintiff's Arguments
- The infringement was deliberately committed to gain an unfair commercial advantage ("stealing a march") over competitors upon patent expiry.
- The statutory provision is broadly worded to remove unjustified profits from infringers; profits made but for the infringement would not have been achieved.
- The fact that profits were realised after patent expiry is irrelevant; the issue of causation and whether profits were derived from infringement requires evidence and cannot be decided against the Plaintiff at this stage.
Table of Precedents Cited
| Precedent | Rule or Principle Cited For | Application by the Court |
|---|---|---|
| Gerber Garment Technology Inc v Lectra Systems Limited and Another [1995] RPC 383 | Recognition of "springboard" damages claims for accelerated market entry due to infringement. | Supported the validity of the Plaintiff’s claim that profits derived from infringement include those gained by early market presence before patent expiry. |
| Gerber Garment Technology Inc v Lectra Systems Limited and Another [1997] RPC 443 (Court of Appeal) | Damages for lost profits are not limited to activities constituting infringement but include post-expiry sales deriving from pre-expiry infringement. | Rejected the argument that post-expiry sales profits should be excluded; court found no rule limiting damages in such a manner. |
| Generics BV v Smith Kline & French Laboratories Limited [1997] RPC 801 (European Court of Justice) | Upheld post-expiry injunctions to prevent unfair profits from infringement; recognized validity of springboard claims under EU law. | Confirmed that remedies preventing unfair profit from infringement, including post-expiry measures, are justified and consistent with Community law. |
| Dyson Appliances v Hoover Limited (No. 2) [2001] RPC 544 | Equitable "springboard relief" injunctions preventing defendants from benefiting commercially after patent expiry due to pre-expiry infringement. | Illustrated the direct nexus between infringement and subsequent commercial advantage, supporting the principle behind the Plaintiff’s claim. |
| Celanese International Corp v BP Chemicals Limited [1997] RPC 203 | Legal causation principles common to both damages and account of profits claims for patent infringement. | Supported the court’s view that causation principles apply similarly to both remedies, reinforcing the Plaintiff’s position. |
Court's Reasoning and Analysis
The court rejected the second Defendant’s submission that profits derived solely from lawful post-expiry sales cannot be attributed to the infringement. It reasoned that when considering the totality of circumstances, including the admitted purpose of the infringement—to gain an unfair commercial advantage—the profits made are properly regarded as derived from the wrongful act. The court emphasized that the remedy sought aims to deprive infringers of unjust profits.
The court found it implausible to sever the chain of legal causation simply because the sales occurred after the patent expired, particularly as the infringement was a necessary antecedent to those sales. The argument that the Defendant might have achieved the advantage by lawful means was insufficient to negate the admitted wrongful conduct.
Precedents concerning springboard claims were found to support the Plaintiff’s position. The court drew on the Gerber cases, the European Court of Justice decision in Generics BV, and the equitable relief granted in Dyson Appliances, all of which recognize that remedies can address profits made after patent expiry when those profits stem from prior infringement.
The court also addressed subsidiary procedural arguments, concluding that the Plaintiff’s pleadings sufficiently notified the Defendants of the basis for claiming profits for 2007 and 2008, despite the complexity of causation and market factors. The court allowed proof before answer to resolve these issues.
Ultimately, the court concluded that the Plaintiff’s claim for an account of profits is not fundamentally irrelevant or beyond the court’s power.
Holding and Implications
HOLDING: The court held that the Plaintiff’s claim for an account of profits derived from the Defendant’s patent infringement, including profits earned post-patent expiry as part of a springboard claim, is valid in principle and not beyond the court’s power.
IMPLICATIONS: This decision confirms that courts in the jurisdiction may order an account of profits reflecting unfair commercial advantage gained through pre-expiry infringement that results in enhanced post-expiry sales. The ruling does not establish new precedent but applies existing legal principles and authorities to affirm the availability of such remedies. The case proceeds to proof to determine the quantum and causal connection of profits claimed. No immediate order as to expenses was made.
Alert